KLAS Contact
Contact KLAS
Contact KLAS
2024 BEST IN KLAS
Preferences
Related Series
2013
Related Segments
UK & Ireland EPR 2024
A Look into Suppliers’ Broader Portfolios
Author
Eder Lagemann
Author
Sidney Tate
Author
Spencer Corbett
Over the last five years, there has been consistent energy around EPR investment and digital transformation in the UK and Ireland—on average, at least six healthcare organisations have made an EPR purchase decision each year. Going forward, activity will likely increase amid integrated care system (ICS) alignment, as over 50 trusts will look to upgrade or deploy their first EPR over the next few years. While going through the complex decision-making process, organisations frequently look for a partner that can provide not only core documentation and ordering functionalities but also additional clinical, administrative and ancillary modules to support their digital transformation. This report includes (1) an overview of the market share and customer satisfaction with EPR suppliers in the UK and Ireland and (2) a look at suppliers’ broader portfolios, diving into the performance and adoption of modules outside of core functionality.
If you don't have a login, getting started is easy.
Key Findings:
- Epic Leads in Customer Satisfaction; MEDITECH* & Nervecentre* Customers See Promise in Latest Versions
- InterSystems Customer Experience Remains Consistent; Oracle Health Customers See Slower Development; System C Customers Note Performance Challenges
- Epic, System C & Oracle Health Experience Highest Growth in Last Five Years
- Epic Customers Report Strong Performance & Adoption across Portfolio; Oracle Health Also Sees Broad Adoption
- InterSystems Customers Report Lower Levels of Performance & Module Adoption
- Altera Digital Health Customers Report Lowest Adoption Levels, Particularly for PAS; Nervecentre* Sees Low Adoption but High Performance across Modules
*Limited data
Writer
Carlisa Cramer
Designer
Natalie Jamison
Project Manager
Sydney Toomer
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.